Dr Charlie Fairhurst is head of children's neurosciences at Evelina London.
He works in a number of specialist teams involved in the management of children with motor difficulties, in particular cerebral palsy. In combination with our orthopaedic teams and gait analysis laboratory, they ensure that children are provided with comprehensive movement therapy at all ages and stages of ability.
Charlie is very experienced in the management of these difficulties, in particular the use of Botulinum Toxin A (Botox) in this group of children, to improve upper and lower limb function, comfort, care, and reduce saliva loss. He is the UK representative on a number of international working parties and is currently the chair of the national NICE guidelines in cerebral palsy.
He sits on the executive boards of the British Academy of Childhood Disability and the British Paediatric Neurology Association and is the chair of the RCPCH’s Specialist Advisory Committee on Neurodisability.
Charlie is a trustee of Whizz-Kidz and works closely with a large number of other charities that work to support children and their families.